Maharashtra Chief Minister Uddhav
Thackeray on Monday launched convalescent plasma therapy-cum- trial project for treatment of critical COVID-19 patients with a state medical education department official calling it the largest initiative of its kind in the world.
Convalescent plasma therapy, also called passive antibody therapy, seeks to obtain plasma from the blood of people who have recovered from the infection to inject into patients undergoing treatment.
"The project, titled 'Platina', is the largest convalescent plasma therapy-cum-trial project in the world. With it, we intend to save lives of some 500 critical COVID-19 patients. The trial will be held in 17 medical colleges under the department of medical education and drugs, and four BMC- run colleges in Mumbai," the official said.
All critical patients will receive two doses of 200 ml convalescent plasma free of cost, he added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)